Clinical trials

4

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Philips FAST SpO2 Technology With Masimo Sensors for SpO2 Monitoring in the Neonatal, Infant, and Pediatric Populations

The objective of this study is to verify the form, fit and function of the Philips FAST technology with Masimo neonatal, infant and pediatric sensors for SpO2 monitoring in the respective indicated populations. The study design uses convenience sample data collection from neonatal, infant, and pediatric sensors within their respective indicated patient populations that have a range of different skin pigmentations, simultaneously with an FDA cleared pulse oximeter as a comparator.

Participants needed: 100
Trial details
Age: 0-21Biological sex: AllType: InterventionalSponsor: Masimo CorporationUpdated: Jul 13, 2026Locations: 2
Eligibility criteria

Subject falls within the indicated population for the Philips FAST SpO2 Monitor... [+1]

Subject has a skin condition or deformity at the planned sensor application site... [+6]

Status: Recruiting

Investigation of Skin Pigmentation Effect on Performance of Masimo Pulse Oximetry (INSPIRE)

The objective of this study is to evaluate the performance of Masimo RD SET® SpO2 sensors in subjects with light and dark skin pigmentation in the intensive care therapeutic area.

Participants needed: 152
Trial details
Age: 18-89Biological sex: AllType: InterventionalSponsor: Masimo CorporationUpdated: May 18, 2026Locations: 1
Eligibility criteria

Subject is 18 years of age or older. [+3]

Subjects in whom pulse oximetry cannot be reliably performed on both the third a... [+6]

Status: Recruiting

Philips FAST SpO2 Technology With Masimo Sensors for SpO2 Monitoring in the Neonatal, Infant, and Pediatric Populations

The objective of this study is to verify the form, fit and function of the Philips FAST technology with Masimo neonatal, infant and pediatric sensors for SpO2 monitoring in the respective indicated populations. The study design uses convenience sample data collection from neonatal, infant, and pediatric sensors within their respective indicated patient populations that have a range of different skin pigmentations, simultaneously with an FDA cleared pulse oximeter as a comparator.

Participants needed: 100
Trial details
Age: 0-21Biological sex: AllType: InterventionalSponsor: Masimo CorporationUpdated: Mar 4, 2026Locations: 2
Eligibility criteria

Subject falls within the indicated population for the Philips FAST SpO2 Monitor... [+1]

Subject has a skin condition or deformity at the planned sensor application site... [+6]

Status: Recruiting

Validation of the Masimo Irregular Heartbeat Detection Algorithm in Participants Without Cardiovascular Disease

Specificity measure of performance of the Irregular Heartbeat Detection algorithm (evaluated for the finger and wrist form factors) against the Masimo Radius VSM® reference ECG. Each form factor will be evaluated independently of one another

Participants needed: 120
Trial details
Age: 18-80Biological sex: AllType: InterventionalSponsor: Masimo CorporationUpdated: Oct 31, 2025Locations: 1
Eligibility criteria

Subject is 18 to 80 years of age. [+3]

Subject currently has a known cardiac disease condition. [+6]